Synopsys, Inc. $SNPS Shares Sold by Montrusco Bolton Investments Inc.

Montrusco Bolton Investments Inc. decreased its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 24.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 153,722 shares of the semiconductor company’s stock after selling 49,047 shares during the quarter. Montrusco Bolton Investments Inc. owned 0.08% of Synopsys worth $66,860,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in shares of Synopsys during the 2nd quarter valued at about $7,228,099,000. Van ECK Associates Corp raised its stake in shares of Synopsys by 19.7% during the second quarter. Van ECK Associates Corp now owns 3,457,249 shares of the semiconductor company’s stock valued at $1,542,175,000 after acquiring an additional 569,687 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Synopsys by 40.7% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,087,349 shares of the semiconductor company’s stock worth $1,377,174,000 after buying an additional 892,736 shares during the last quarter. Assenagon Asset Management S.A. increased its stake in shares of Synopsys by 39.5% during the second quarter. Assenagon Asset Management S.A. now owns 2,455,402 shares of the semiconductor company’s stock valued at $1,095,281,000 after buying an additional 695,146 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Synopsys during the second quarter valued at approximately $747,400,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Insider Transactions at Synopsys

In related news, CFO Sudhindra Kankanwadi sold 9,170 shares of the stock in a transaction that occurred on Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the completion of the transaction, the chief financial officer directly owned 22,717 shares of the company’s stock, valued at approximately $11,358,500. This represents a 28.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Aart de Geus sold 24,641 shares of the firm’s stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $419.44, for a total value of $10,335,421.04. Following the transaction, the insider owned 120,443 shares of the company’s stock, valued at $50,518,611.92. This represents a 16.98% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 102,559 shares of company stock valued at $44,607,141 over the last three months. Corporate insiders own 0.56% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on the company. Wells Fargo & Company lifted their price objective on Synopsys from $475.00 to $540.00 and gave the company an “overweight” rating in a research report on Thursday, October 1st. Morgan Stanley decreased their target price on shares of Synopsys from $525.00 to $500.00 and set an “equal weight” rating for the company in a report on Wednesday, August 19th. HSBC downgraded Synopsys from a “buy” rating to a “reduce” rating in a report on Friday, September 25th. Piper Sandler raised Synopsys from a “neutral” rating to an “overweight” rating and increased their price target for the company from $450.00 to $550.00 in a report on Tuesday, June 23rd. Finally, Roth Capital upgraded shares of Synopsys to a “buy” rating in a research report on Friday, September 25th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $571.78.

Synopsys Price Performance

SNPS traded down $8.00 during trading on Tuesday, hitting $494.51. 2,520,300 shares of the company traded hands, compared to its average volume of 2,044,608. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The company has a market cap of $94.77 billion, a PE ratio of 87.37, a P/E/G ratio of 2.08 and a beta of 1.21. The stock’s 50-day simple moving average is $423.97 and its two-hundred day simple moving average is $440.26. Synopsys, Inc. has a 1 year low of $362.55 and a 1 year high of $539.48.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, topping the consensus estimate of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The business had revenue of $2.48 billion for the quarter, compared to analysts’ expectations of $2.44 billion. During the same quarter in the previous year, the company earned $3.39 EPS. The business’s quarterly revenue was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, sell-side analysts anticipate that Synopsys, Inc. will post 10.97 earnings per share for the current fiscal year.

Synopsys declared that its board has authorized a share repurchase plan on Monday, October 5th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the semiconductor company to reacquire up to 1.1% of its shares through open market purchases. Share repurchase plans are generally an indication that the company’s board of directors believes its shares are undervalued.

Synopsys Company Profile

Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and software tools used to design, verify, and manufacture advanced electronic systems. Its solutions support the development of semiconductors, systems-on-chip, and electronic products across the design cycle, from initial specification and architecture through testing and production.

The company’s offerings include digital and custom integrated-circuit design tools, simulation and verification software, physical design and signoff products, and semiconductor IP such as processor cores, interface technologies, and foundational components.